2FX as a barrier excipient: novel applications in nasal, udder, skin, and liquid formulations
In addition to its integration within finished products, 2FX is also available as a ready-to-use liquid excipient. Supplied in concentrated form, this variant provides pharmaceutical and over-the-counter (OTC) companies with a versatile foundation for product development.
The liquid format allows seamless incorporation of the patented 2FX complex into a wide range of generic formulations. By supplying 2FX under a license agreement, manufacturers gain direct access to a scientifically validated barrier technology without the need for extensive in-house R&D.
The positioning of 2FX pure liquid highlights several advantages:
-
Flexibility: suitable for integration into diverse pharmaceutical and OTC product categories.
-
Turnkey innovation: enables rapid product differentiation using a proven, patented excipient.
-
Licensing model: ensures reliable supply while safeguarding intellectual property.
-
Market applicability: supports both human and veterinary health markets with broad potential use cases.
In this form, 2FX serves as an innovation enabler, offering companies the opportunity to enhance existing formulations or to create entirely new solutions based on a clinically supported, biofilm-forming technology.
